Combined MDM2 and G2/M checkpoint inhibition induces synergistic antitumor response in gastric signet-ring cell carcinoma
- 31 January 2025
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 613, 217500
Abstract
No abstract availableKeywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province
- Bethune Ethicon Excellent Surgery Foundation
- National Natural Science Foundation of China
This publication has 43 references indexed in Scilit:
- Inflammatory cytokine-regulated LNCPTCTS suppresses thyroid cancer progression via enhancing Snail nuclear exportCancer Letters, 2023
- Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myelomaCancer Letters, 2023
- SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axisCancer Letters, 2023
- Patient-derived organoids in translational oncology and drug screeningCancer Letters, 2023
- Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma modelGastric Cancer, 2022
- Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutationsGastric Cancer, 2021
- MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53Cancer Letters, 2019
- Is signet-ring cell carcinoma a specific entity among gastric cancers?Gastric Cancer, 2015
- Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potentialGastric Cancer, 2012
- Signet ring cell differentiation in mucinous colorectal carcinomaThe Journal of Pathology, 2007